Definium Therapeutics (DFTX) Stock Hits 52-Week High as Trump Backs Psychedelic Medicine Research
TLDR DFTX stock surged over 13% in premarket trading after President Trump signed an Executive Order backing psychedelic drug research for mental health treatment The...












